Published: 12. February, 2024
Giving medicine to children can’t be a one-size-fits-all approach. Their changing anatomy and…
Giving medicine to children can’t be a one-size-fits-all approach. Their changing anatomy and physiology demand tailored trials, formulations, and vigilance. Developing CT001, required specialised paediatric research.
✅ We have conducted 2 clinical trials in children and 2 in adults for CT001.
✅ Ongoing modeling, simulations, and real-world evidence also inform our approach, as well as a final safety study in children.
✅ This almost completed comprehensive effort optimises CT001 for children.
Our goal is maximum benefit and minimum risk for our youngest patients.
